Dr. Stephen E Litman, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1533 Jarrettown Rd, Dresher, PA 19025 Phone: 215-914-5620 |
Lance Leopold, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1441 Catlin Way, Dresher, PA 19025 Phone: 610-203-9328 Fax: 866-305-6063 |
Dr. Mark Steven Kramer, M.D., PH.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1412 Lantern Cir, Office #200, Dresher, PA 19025 Phone: 215-498-1820 |
Dr. Randi Leavitt, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1716 Somerset St, Dresher, PA 19025 Phone: 215-830-8789 |
News Archive
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference therapeutics, announced today it has initiated patient dosing in a Phase 1 human clinical trial for its lead oncology product, TKM-PLK1. TKM-PLK1 targets polo-like kinase 1, or PLK1, a cell cycle protein involved in tumor cell proliferation and a validated oncology target.
Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.
"The World Health Organization (WHO) has for the first time recommended limits on children's daily consumption of sodium which it hoped would help in the global fight against diet-related diseases becoming chronic among all populations," Reuters reports, adding, "The guidelines vary depending on the child's size, age and energy needs, and apply to children over the age of two."
The University of Michigan, University of California Los Angeles, University of Pennsylvania and Yale University have teamed up to launch a new initiative to educate nurses and physicians together to serve as leaders, researchers and change agents in health care, community health and public policy.
Laureate Pharma, Inc. a US based biopharmaceutical contract manufacturing organization and Selexis SA, a Swiss based contract developer of high performance production cell lines, jointly announced today their continued collaboration via a joint-marketing relationship. This expanded relationship provides streamlined access to a set of highly complementary contract services.
› Verified 5 days ago